Sun Pharma announces structural changes in bid to repair reputation; puts out clarification
Sun Pharma announces key structural changes to deal with a dent in its image and plummeting stock prices22-01-2019
22-01-2019
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
We are pleased to enclose herewith our Press Release relating to ' Investor Update', which we shall be releasing after sending this letter to you. This is for your information and record.22-01-2019
'Sun Pharma trying to shoot the messenger'
Even if they are not hiding, they are not giving a convincing answer, says Subramanian.21-01-2019
Sun Pharmaceutical Industries Ltd - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raksha Sudhir Valia21-01-2019
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Statement Of Investor Complaints For The Quarter Ended December 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Sunil AjmeraDesignation :- Company Secretary and Compliance Officer18-01-2019
Sun Pharmaceutical Industries Ltd - 524715 - Shareholding for the Period Ended December 31, 2018
Sun Pharmaceutical Industries Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here18-01-2019
Sun Pharma should change board and come clean: InGovern
Sun Pharma must say they are not going to have any transaction with Aditya Medisales going forward.18-01-2019
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Our Letter To SEBI On A Media Report Regarding Alleged Second Whistleblower Complaint Filed Against Our Company
We are enclosing herewith our letter, dated January 18, 2019, sent today to The Chairman, Securities and Exchange Board of India (SEBI) on a media report regarding alleged second whistleblower complaint filed against our Company. This is for your information and records.18-01-2019
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Clarifies on news item
With reference to news appeared in www.moneycontrol.com dated January 18, 2019 quoting "Sun Pharma plummets over 12% over buzz of fresh whistle-blower complaint", Sun Pharmaceutical Industries Ltd has submitted to BSE a copy of Clarification is enclosed.18-01-2019
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Clarification sought from Sun Pharmaceutical Industries Ltd
The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd on January 18, 2019, with reference to news appeared in www.moneycontrol.com dated January 18, 2019 quoting "Sun Pharma plummets over 12% over buzz of fresh whistle-blower complaint".The reply is awaited.18-01-2019